German Chancellor, Ministers Get Special Vaccine Without Soft Kill Ingredients

The revelation that the German Chancellor Angela Merkel as well the cabinet, including the Health Minister Ulla Schmidt are planning to take a "swine flu" jab without mercury and squalene is fuelling fears in Germany that there is a two tier vaccination system planned; a safe vaccine for the global elite and their agents in national governments, and a lethal vaccine for the rest of the population. Wolf Dieter Ludwig, head of the medicines commission of the association of German doctors, called the decision by the government to take a different vaccine from the untested and toxic swine flu jab destined for the rest of the population a "scandal" of a dimension that can hardly be communicated to the general public. "The health authorities have fallen for a campaign from the pharmaceutical companies, who just want to earn money with an illusory threat," Ludwig said. Vaccines with adjuvants have not been tested on pregnant women and children even though the German govenrment has said these are priority groups. Among the government officials to get the "swine flu" jab without mercury and adjuvants will be the employees of the Paul Ehrlich Institute, the government drug regulator which ordered "swine flu" jabs with mercury and squalene to the rest of the population.

The German army has ordered a stock of special swine flu vaccine that does not contain controversial additives that will be given to the general public, the Defence Ministry confirmed on Monday.The announcement came in response to a report in daily Westfalen-Blatt, which said that Bundeswehr soldiers and their families on foreign deployments or preparing for missions overseas would receive the inoculations.

The A/H1N1 flu shots given to soldiers will contain neither a controversial strengthening additive, nor the preservative agent mercury, both of which are contained in the shots for the general public.

Additive-free Celvapan, manufactured by the US pharmaceutical company Baxter, was approved on October 6 for use in the European Union.

Open rebellion prevails among general practitioners and paediatricians. The President of the German Society of General Medicine and Family Medicine, Michael cooking, advises the German GPs from the vaccine. "The risk of harm outweighs the benefits," says the Gottingen professor. Wolfram Hartmann, president of the Professional Association of Child and Adolescent Physicians, accuses the government of "scientific misinformation before. As for pregnant women, it also applied to children under three years: "This vaccine is not tested on them at all, so the risk is simply too big to use it now without hesitation."